This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The use of acupuncture for the treatment of withdrawal symptoms from drugs of abuse has been studied for greater than three decades. The mechanism by which the effect of acupuncture reduces withdrawal symptoms is believed to be mediated by endogenous opiate release in the brain. Nitric oxide (NO) research has shown that acupuncture points contain higher levels of NO locally and enhance neuronal NO synthase (nNOS) expression centrally, when stimulated. Elevated levels of nNOS in the brain have been shown to correlate with raised levels of central norepinephrine (NE). The purpose of this study is to examine the effects of acupuncture on methamphetamine withdrawal symptoms and to examine the hypothesis that improvement will be due to raised nNOS in the brain and consequent NE levels caused by the acupuncture treatment. Published research has examined cocaine, alcohol, and opiates with findings that generally support the effectiveness of acupuncture. There has been no investigation, however, evaluating the effect of acupuncture on methamphetamine (MA) withdrawal symptoms. Compared to cocaine, withdrawal syndrome from MA takes longer to resolve and therefore offers greater opportunity for elucidating acupuncture-induced NO changes. Placebo treatment will use acupuncture at ear and body locations not used for any traditional indication. Subjects will provide urine specimens for drug content after each acupuncture session and will receive 1-hour counseling 3 times a week. Once a week group therapy will also be provided. Plasma NE concentrations, nitrite, and nitrate will be taken before treatment on day 1 and after treatment on day 7 and 14. On day 1 and 14, skin NO levels will be measured before, during, and after acupuncture treatments. In addition, measures of methamphetamine withdrawal will be evaluated using the Beck Depression and Anxiety scales. Patients receiving sham and experimental acupuncture will receive these scales at baseline and before and after treatments (before counseling) on days 1, 3, 7 and 14. At 60 and 90 days post-treatment, subjects will also be tested for urine toxicology and be given the Addiction Severity Index.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000425-39
Application #
7717270
Study Section
Special Emphasis Panel (ZRR1-CR-5 (01))
Project Start
2007-12-01
Project End
2008-11-30
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
39
Fiscal Year
2008
Total Cost
$730
Indirect Cost
Name
La Biomed Research Institute/ Harbor UCLA Medical Center
Department
Type
DUNS #
069926962
City
Torrance
State
CA
Country
United States
Zip Code
90502
Mehta, Puja K; Hermel, Melody; Nelson, Michael D et al. (2018) Mental stress peripheral vascular reactivity is elevated in women with coronary vascular dysfunction: Results from the NHLBI-sponsored Cardiac Autonomic Nervous System (CANS) study. Int J Cardiol 251:8-13
Kim, Se-Min; Cui, Jinrui; Rhyu, Jane et al. (2018) Association between site-specific bone mineral density and glucose homeostasis and anthropometric traits in healthy men and women. Clin Endocrinol (Oxf) 88:848-855
Sharma, Shilpa; Mehta, Puja K; Arsanjani, Reza et al. (2018) False-positive stress testing: Does endothelial vascular dysfunction contribute to ST-segment depression in women? A pilot study. Clin Cardiol 41:1044-1048
Shufelt, Chrisandra; Manson, Joann (2018) Managing Menopause by Combining Evidence With Clinical Judgment. Clin Obstet Gynecol 61:470-479
Cherukuri, Lavanya; Smith, Michael S; Tayek, John A (2018) The durability of oral diabetic medications: Time to A1c baseline and a review of common oral medications used by the primary care provider. Endocrinol Diabetes Metab J 2:
Nicholls, Stephen J; Tuzcu, E Murat; Wolski, Kathy et al. (2018) Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Cardiovasc Diagn Ther 8:405-413
Wei, Janet; Bakir, May; Darounian, Navid et al. (2018) Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study. Circulation 137:874-876
Elboudwarej, Omeed; Wei, Janet; Darouian, Navid et al. (2018) Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction study. Int J Cardiol 268:230-235
Shufelt, Chrisandra; Bairey Merz, C Noel; Pettinger, Mary B et al. (2018) Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study. Menopause 25:985-991
Humphries, K H; Izadnegahdar, M; Sedlak, T et al. (2017) Sex differences in cardiovascular disease - Impact on care and outcomes. Front Neuroendocrinol 46:46-70

Showing the most recent 10 out of 1232 publications